William Murray has been appointed division president, molecular biology at Applied Biosystems, the company said yesterday. He takes over for Catherine Burzik, the current president of Applied Biosystems, who had been leading the division since the company announced a restructuring last summer.
Beckman Coulter has named Scott Garrett as its CEO, effective Feb. 21, the company said last week. Garrett, who is currently president and chief operating officer, will replace current CEO John Wareham, who is retiring.
Stephen Oldfield has left his position of vice president of worldwide marketing for Molecular Devices, Inside Bioassays, a GenomeWeb publication, has learned. A company spokesperson declined to provide details regarding Oldfield's departure. Molecular Devices said it has named Jan Hughes as the new vice president of worldwide marketing. Hughes previously was vice president of product development for Molecular Devices' high-throughput electrophysiology division.
Samraat Raha, former vice president of GE Healthcare's CodeLink microarray product line, has joined Agilent Technologies' Life Science and Chemical Analysis business unit as vice president of field operations for the
Evotec OAI said last week that Mary Tanner has been elected to the company's supervisory board. Tanner has 22 years of senior-level management experience in healthcare and consumer products at Lehman Brothers and Bear Stearns, Evotec said. Tanner retired from Bear Stearns in 2004, and founded Life Sciences Partners, a healthcare investment and advisory firm. Tanner obtained a degree from
The Chemical Heritage Foundation (CHF) has selected James D. Watson, co-discoverer of the structure of DNA, to receive the 2005 Othmer Gold Medal. The award ceremony and annual Othmer Gold Medal Luncheon will take place at CHF in
James Bruce has been named CEO of Sciona, a
James Jordan has joined the Pittsburgh Life Sciences Greenhouse as an executive-in-residence focusing on the development of early-stage companies and commercialization of later-stage technologies and opportunities.
Cy Steinhas joined the scientific advisory board of Berlin-based Atugen. Stein is head of medical genitourinary oncology and professor of medicine, urology and molecular pharmacology at the Albert Einstein College of Medicine. He co-developed Genta's Genasense, an antisense treatment for BCL-2-dependent breast cancer. Stein currently serves as co-editor of the journal Oligonucleotides.
Sirna Therapeuticshas appointed Rebecca Galler Robison to the post of senior director of corporate strategy, a newly created position at the company. Robison most recently served as director of private equity at Invesco Funds Group.
John Lislehas been named CEO of Inpharmatica. He most recently served as CEO of Profile Therapeutics. Malcolm Weir, Inpharmatica's current CEO will remain in the role of chief scientific officer.
David Smith, who served as senior vice president and general counsel of TissueInformatics until its merger with Icoria last February, has joined law firm Pepper Hamilton's intellectual property practice group in
Russell Medford, president and CEO of AtheroGenics, has been elected chair of the Georgia Biomedical Partnership.
Jim Parinahas been named director of sales and business development for Expression Analysis, the Durham, NC-based firm said last week. He previously was a pharmaceutical business development manager at Applied Biosystems and a sales manager at PerkinElmer.
Fairfield Sensorshas appointed Louise Madden to the position of financial director. She previously served as an accountant with KPMG.
Kristen Andersonhas been named senior vice president of human resources at Abgenix. She joins the firm from Applied Biosystems, where she served as vice president of human resources.
Jonathan Kuwabara-Wagg has joined Pharsight as a senior scientist in the firm's drug development consulting division. He will report to Russell Wada, vice president, drug development consulting services, West Coast and